SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-038757
Filing Date
2024-05-02
Accepted
2024-05-02 08:10:50
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0204430-10q_protara.htm   iXBRL 10-Q 600347
2 AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ea020443001ex10-1_protara.htm EX-10.1 14782
3 RETENTION BONUS, EFFECTIVE AS OF JANUARY 25, 2024, BY AND BETWEEN REGISTRANT AND ea020443001ex10-2_protara.htm EX-10.2 11331
4 CERTIFICATION ea020443001ex31-1_protara.htm EX-31.1 13091
5 CERTIFICATION ea020443001ex31-2_protara.htm EX-31.2 13265
6 CERTIFICATION ea020443001ex32-1_protara.htm EX-32.1 8495
7 GRAPHIC ex10-2_001.jpg GRAPHIC 2467
8 GRAPHIC ex10-2_002.jpg GRAPHIC 2135
9 GRAPHIC ex10-2_003.jpg GRAPHIC 5497
  Complete submission text file 0001213900-24-038757.txt   4333300

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE tara-20240331.xsd EX-101.SCH 50033
11 XBRL CALCULATION FILE tara-20240331_cal.xml EX-101.CAL 36334
12 XBRL DEFINITION FILE tara-20240331_def.xml EX-101.DEF 211911
13 XBRL LABEL FILE tara-20240331_lab.xml EX-101.LAB 395778
14 XBRL PRESENTATION FILE tara-20240331_pre.xml EX-101.PRE 211559
78 EXTRACTED XBRL INSTANCE DOCUMENT ea0204430-10q_protara_htm.xml XML 447756
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 24905447
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)